Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Mar 16, 2021 10:29am
286 Views
Post# 32806959

RE:RE:RE:RE:RE:RE:Winnipeg Lab

RE:RE:RE:RE:RE:RE:Winnipeg Lab
99942Apophis wrote: Thank you ScienceFirst, I was under the opinion the company (TLT) would be concentrating their efforts on this Ph2 NMIBC and PH1 Brain & Lung before funding a Coronavirus vaccine since there is sufficient remedies out there all in my opinion. I would guess once TLT does go into vaccine trial it might treat the entire family of Coronavirus instead of just one strain or perhaps I don't fully understand the power of TLD-1433 enough to grasp what it can or can not do. My concern here is they tackle the destruction of Cancer and I would prefer if they found some other company to partnership with and let them fund the trials but again all in my uneducated opinion.


Apop, I think the possibility of some good pre-clinical 1433 data on Covid 19 would boost SP. Because of the potential of, like you've said, partnerships or Govt. grant money $$ etc. Yes, a cure for Covid, Sars, Ebola, and the common cold! Not bad!
<< Previous
Bullboard Posts
Next >>